@article{16277, keywords = {Age Factors, Antibodies, Bacterial, BCG Vaccine, Female, Humans, Immunity, Maternally-Acquired, Immunoglobulin A, Immunoglobulin G, Immunoglobulin M, Immunoglobulins, Infant, Infant, Newborn, leprosy, Mycobacterium leprae, Pregnancy, Radioimmunoassay}, author = {Melsom R and Harboe M and Duncan M E}, title = {IgA, IgM and IgG anti-M. leprae antibodies in babies of leprosy mothers during the first 2 years of life.}, abstract = {

IgA, IgM and IgG anti-M. leprae antibody activity was estimated by solid phase radioimmunoassay in repeated serum samples from cord sera to sera taken 2 years after birth from 29 babies of mothers with lepromatous leprosy (Group 1) and 16 babies of mothers with tuberculoid leprosy and non-leprosy control mothers (Group 2). IgA anti-M. leprae antibody activity could be detected in 30% and IgM anti-M. leprae antibody activity in 50% of cord sera from Group 1, but not in any of the cord sera from Group 2. After birth, there was a significantly higher increase of IgA and IgM anti-M. leprae antibody activity in sera taken 3-6 months after birth from babies of Group 1 compared to Group 2, but the IgA and IgM activity in sera taken after 6 months of age showed the same increase in the two groups. IgG anti-M. leprae antibody activity showed a marked decrease in sera from both Groups 1 and 2 taken 3-6 and 6-9 months after birth compared to the activity in the cord sera. No increase of the IgG activity could be demonstrated even in sera taken 15-24 months after birth in any of the two groups. These findings are discussed in relation to possible transfer of M. leprae bacilli across the placenta, the influence of M. leprae and other mycobacteria exposure on the antibody activity, the poor IgG anti-M. leprae antibody response and subclinical leprosy infection in babies exposed to leprosy below 2 years of age.

}, year = {1982}, journal = {Clinical and experimental immunology}, volume = {49}, pages = {532-42}, month = {1982 Sep}, issn = {0009-9104}, url = {https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1536716/pdf/clinexpimmunol00168-0042.pdf}, language = {eng}, }